IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,778,459 | -41.4% | 252,622 | -49.2% | 0.01% | -36.8% |
| Q1 2023 | $3,036,542 | -23.1% | 496,979 | -19.5% | 0.02% | -17.4% |
| Q4 2022 | $3,946,598 | -9.9% | 617,621 | +35.2% | 0.02% | -8.0% |
| Q3 2022 | $4,378,000 | +46.8% | 456,947 | +69.1% | 0.02% | +38.9% |
| Q2 2022 | $2,983,000 | -16.9% | 270,238 | +25.3% | 0.02% | -40.0% |
| Q1 2022 | $3,590,000 | +0.1% | 215,645 | +14.8% | 0.03% | -11.8% |
| Q4 2021 | $3,585,000 | -43.1% | 187,785 | -26.4% | 0.03% | -57.0% |
| Q3 2021 | $6,296,000 | +23218.5% | 255,299 | +24400.9% | 0.08% | – |
| Q2 2021 | $27,000 | -99.1% | 1,042 | -98.9% | 0.00% | -100.0% |
| Q1 2021 | $3,123,000 | +144.4% | 98,642 | +258.3% | 0.04% | +122.2% |
| Q4 2020 | $1,278,000 | +34.5% | 27,534 | -4.6% | 0.02% | +28.6% |
| Q3 2020 | $950,000 | -88.0% | 28,851 | -90.0% | 0.01% | -89.8% |
| Q2 2020 | $7,903,000 | +1219.4% | 287,903 | +1231.2% | 0.14% | +1145.5% |
| Q4 2019 | $599,000 | -39.1% | 21,628 | -60.0% | 0.01% | -45.0% |
| Q3 2019 | $984,000 | +720.0% | 54,067 | +1000.3% | 0.02% | +900.0% |
| Q2 2019 | $120,000 | -43.1% | 4,914 | -77.8% | 0.00% | -71.4% |
| Q1 2019 | $211,000 | +66.1% | 22,150 | +54.0% | 0.01% | +16.7% |
| Q4 2018 | $127,000 | -47.3% | 14,385 | +0.7% | 0.01% | -57.1% |
| Q1 2018 | $241,000 | – | 14,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |